People · Operator
Named in public records as an officer, director or promoter · active 2022–2023 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avenda Health, Inc. | — | Healthtech | Series A | $15.3M | $26.0M | 2022 |
Ronald D. Sugar, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ronald D. Sugar, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Klein | 1 | 9 |
| Michael N. Klein | 1 | 1 |
| Leonard S. Marks, M.D. | 1 | 1 |
| Shyam Natarajan, Ph.D. | 1 | 1 |
| Brittany N. Pusey, Ph.D. | 1 | 1 |
| Leonard Marks, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.